Laronde: Former Rubius CEO to lead buzzy Flagship startup
Pablo Cagnoni was appointed CEO at the RNA drug startup Laronde days after departing Rubius, a once high flying biotech that's now laid off nearly all its employees and is seeking a sale.
Read full article »
Laronde is a Massachusetts-based biotechnology firm that researches and develops novel eRNA therapeutics for the treatment of cancer.
Read more